Willis Towers Watson (WTW) awards restricted share units to executive

Rhea-AI Filing Summary

Willis Towers Watson PLC reported that officer Julie Jarecke Gebauer, President of Health, Wealth & Career, acquired 81.6596 restricted share units on March 3, 2026 as a grant or award. Following this transaction, she held 5,574.2940 restricted share units directly.

According to the company’s Non-Qualified Stable Value Excess Plan for U.S. Employees, vested restricted share units settle into ordinary shares on a 1:1 basis. Settlement occurs on the first business day of an eligible month after separation from service or after the participant’s death, based on the plan’s specified timing rules.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Gebauer Julie Jarecke

Role Pres.-Health, Wealth & Career

Type	Security	Shares	Price	Value
Grant/Award	Restricted Share Unit	81.66	$0.00	--

Holdings After Transaction: Restricted Share Unit — 5,574.294 shares (Direct)

Footnotes (1)

1. Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. Includes restricted share units credited to the participant's account by the Company pursuant to the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees (the "Plan") accrual formula, net of the units acquired pursuant to the participant's contribution under the Plan.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gebauer Julie Jarecke

(Last) (First) (Middle)

C/O WILLIS GROUP LIMITED

51 LIME STREET

(Street)

LONDON X0 EC3M 7DQ

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
WILLIS TOWERS WATSON PLC [ WTW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Pres.-Health, Wealth & Career

3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Share Unit	(1)	03/03/2026		A		81.6596(2)		(1)	(1)	Ordinary Shares, nominal value $0.000304635 per share	81.6596	$0	5,574.294	D

Explanation of Responses:

1. Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death.

2. Includes restricted share units credited to the participant's account by the Company pursuant to the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees (the "Plan") accrual formula, net of the units acquired pursuant to the participant's contribution under the Plan.

	/s/ Julie J. Gebauer by Lina Vanessa Jaramillo, Attorney-in-Fact (power of attorney previously filed)	03/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did WTW executive Julie Jarecke Gebauer report?

Julie Jarecke Gebauer reported acquiring 81.6596 restricted share units as a grant or award. After this March 3, 2026 transaction, she directly held a total of 5,574.2940 restricted share units under the company’s compensation arrangements.

How many Willis Towers Watson restricted share units does the WTW executive hold after the Form 4 transaction?

After the reported grant, the executive directly held 5,574.2940 restricted share units. This total reflects the newly acquired 81.6596 units combined with her prior holdings, as disclosed in the beneficial ownership figure following the transaction.

What is the nature of the WTW restricted share units granted to the executive?

The filing describes the securities as restricted share units granted as a "grant, award, or other acquisition." These units are credited under Willis Towers Watson’s Non-Qualified Stable Value Excess Plan for U.S. Employees pursuant to the plan’s accrual formula.

How and when do WTW restricted share units under the Non-Qualified Stable Value Excess Plan settle?

Vested restricted share units settle into ordinary shares on a 1:1 basis. Settlement occurs on the first business day of a month when NASDAQ is open, following specified timing related to separation from service or death, as outlined in the plan terms.

What share conversion terms apply to WTW restricted share units in this Form 4?

The filing states that vested restricted share units settle for ordinary shares with a nominal value of $0.000304635 per share. The conversion is on a 1:1 basis under the Non-Qualified Stable Value Excess Plan for U.S. Employees.

Are the WTW restricted share units in this Form 4 part of a specific employee plan?

Yes. The filing notes the units are credited under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees, using the plan’s accrual formula and reflecting units net of the participant’s own contributions under the plan.